BICX (BioCorRx) Accounts Payable & Accrued Expense : $10.86 Mil (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Accounts Payable & Accrued Expense?

BioCorRx's quarterly accounts payable & accrued expense declined from Sep. 2024 ($5.66 Mil) to Dec. 2024 ($5.56 Mil) but then increased from Dec. 2024 ($5.56 Mil) to Mar. 2025 ($10.86 Mil).

BioCorRx's annual accounts payable & accrued expense increased from Dec. 2022 ($3.91 Mil) to Dec. 2023 ($4.61 Mil) and increased from Dec. 2023 ($4.61 Mil) to Dec. 2024 ($5.56 Mil).

BioCorRx Accounts Payable & Accrued Expense Historical Data

The historical data trend for BioCorRx's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Accounts Payable & Accrued Expense Chart

BioCorRx Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2.48

3.19

3.91

4.61

5.56

BioCorRx Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.98	5.29	5.66	5.56	10.86

BioCorRx Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

BioCorRx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806

Website

https://www.biocorrx.com

BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.

Executives

Louis C. Lucido	director	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan	director, 10 percent owner	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy	director	5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola	director	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch	officer: Vice President of Operations	10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry	director, officer: Chief Executive Officer	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier	director	13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix	director, officer: Chief Financial Officer	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade	director, officer: Chief Executive Officer	PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr	director, officer: President	13231 SANDHURST PLACE, SANTA ANA CA 92705